Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Vicki Antonenas"'
Autor:
David J. Gottlieb, Gaurav Sutrave, Wei Jiang, Selmir Avdic, Janine A. Street, Renee Simms, Leighton E. Clancy, Vicki Antonenas, Brian S. Gloss, Caroline Bateman, David C. Bishop, Kenneth P. Micklethwaite, Emily Blyth
Publikováno v:
American Journal of Hematology. 98:159-165
We designed a trial to simultaneously address the problems of graft versus host disease (GVHD), infection, and recurrence of malignancy after allogeneic stem cell transplantation. CD34
Autor:
Shruthi Subramanian, Julie A.I. Thoms, Yizhou Huang, Paola Cornejo, Forrest C. Koch, Sebastien Jacquelin, Sylvie Shen, Emma Song, Swapna Joshi, Chris Brownlee, Petter S. Woll, Diego Chacon Fajardo, Dominik Beck, David J. Curtis, Kenneth Yehson, Vicki Antonenas, Tracey O’ Brien, Annette Trickett, Jason A. Powell, Ian D. Lewis, Stuart M. Pitson, Maher K. Gandhi, Steven W. Lane, Fatemeh Vafaee, Emily S. Wong, Berthold Göttgens, Hamid Alinejad Rokny, Jason W.H Wong, John E. Pimanda
SummaryHematopoietic stem and progenitor cells (HSPCs) rely on a complex interplay of transcription factors (TFs) to regulate differentiation into mature blood cells. A heptad of TFs - FLI1, ERG, GATA2, RUNX1, TAL1, LYL1, LMO2 - bind regulatory eleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41942e05e1ce4a56162d13a406b33d8c
https://doi.org/10.1101/2023.04.18.537282
https://doi.org/10.1101/2023.04.18.537282
Autor:
Lucy E Cain, Katherine Stephen, Vicki Antonenas, Kay Montgomery, Belinda Meares, Melissa A Gabriel
Publikováno v:
Transplantation and Cellular Therapy. 29:S127-S128
Autor:
David O Irving, Koon H Lee, David Gottlieb, Jane Burgess, Wei Jiang, Georgia McCaughan, Kenneth P. Micklethwaite, Vicki Antonenas, Gaurav Sutrave, Janine A Street, Emily Blyth, Tracey A. O'Brien, Elissa Atkins, Helen M. McGuire, Karen Maddock, Geetha Mathew, David Bishop, Selmir Avdic, Leighton Clancy, Brian S. Gloss, Peter J. Shaw, Renee Simms, Leili Moezzi
Publikováno v:
Blood. 138:1504-1509
Autor:
Lucy E Cain, Katherine Stephen, Vicki Antonenas, Kay Montgomery, Belinda Meares, Melissa A Gabriel
Publikováno v:
Blood. 140:12809-12810
Autor:
Bartlomiej Getta, Emily Blyth, Vicki Antonenas, Megan Hogg, Ian Bilmon, Shyam Panicker, Abir Bhattacharyya, John Kwan, David Collins, Stephanie Deren, Gillian Huang, David Gottlieb, Daochen Tong, Kenneth P. Micklethwaite
Publikováno v:
Internal Medicine Journal. 50:299-306
BACKGROUND Donor safety is paramount when performing bone marrow stem cell harvest. The incidence of full blood count (FBC) abnormalities among donors and variables associated with anaemia after marrow harvest are not well established. AIMS To descri
Autor:
Wei Jiang, Leighton E. Clancy, Selmir Avdic, Gaurav Sutrave, Janine Street, Renee Simms, Helen M. McGuire, Ellis Patrick, Adam S. Chan, Georgia McCaughan, Nadav Myers, Kenneth P. Micklethwaite, Vicki Antonenas, Adrian G. Selim, David Ritchie, Caroline M. Bateman, Peter J. Shaw, Emily Blyth, David J. Gottlieb
Publikováno v:
Blood advances. 6(17)
Virus-specific T-cells (VSTs) from third-party donors mediate short- and long-term antiviral effects in allogeneic hematopoietic stem cell transplant (HSCT) recipients with relapsed or refractory viral infections. We investigated early administration
Autor:
Cheryl Hutchins, Anne Marie Watson, Karieshma Kabani, Nada Hamad, Elizabeth O'Flaherty, Duncan Purtill, Daochen Tong, Glen A Kennedy, David J. Curtis, David Gottlieb, Vicki Antonenas, Ashish Bajel, Matthew Greenwood, Li Jun Bai, Paul Chiappini, Suikeat Tan, Stephen Larsen
Publikováno v:
Blood Advances
Key Points CD34+ cell recovery and viability are variable after thawing cryopreserved hematopoietic progenitor cell products.Reduced CD34+ cell recovery and viability are linked to longer storage time and higher white cell concentration before cryopr
Autor:
Shyam Panicker, Emily Blyth, Gillian Huang, David Gottlieb, Kenneth P. Micklethwaite, David Kliman, John Kwan, Vicki Antonenas, Ian Bilmon, Stephanie Deren, Abir Bhattacharyya
Publikováno v:
Internal Medicine Journal. 48:988-991
Graft failure affects approximately 5% of allogeneic stem cell transplants, with a poor prognosis. Salvage second allogeneic stem cell transplantation (alloSCT2) is limited by high rates of transplant-related mortality from infection and graft-versus
Autor:
Leanne Purins, Karieshma Kabani, Cheryl Hutchins, Andrea McClean, Matthew Greenwood, David J. Curtis, Peter J. Shaw, Duncan Purtill, David D.F. Ma, Kenneth P. Micklethwaite, Vicki Antonenas, Nada Hamad, Chris Fraser, Paul Chiappini, Sarah Tan, Helen Tao, Ashish Bajel, Lijun Bai, David Gottlieb, Glen A Kennedy, Travis Perera, Andrew Butler, Elizabeth O'Flaherty
Publikováno v:
Transplantation and Cellular Therapy. 27:1022.e1-1022.e6
BACKGROUND: Changes to donor availability, collection centre capacity and travel restrictions during the early phase of the COVID-19 pandemic led to routine cryopreservation of most unrelated donor products for haematopoietic transplantation prior to